303 related articles for article (PubMed ID: 15454246)
1. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.
Burger AM; Seth AK
Eur J Cancer; 2004 Oct; 40(15):2217-29. PubMed ID: 15454246
[TBL] [Abstract][Full Text] [Related]
2. Targeting E3 ubiquitin ligases for cancer therapy.
Sun Y
Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
[TBL] [Abstract][Full Text] [Related]
3. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
Soucy TA; Smith PG; Rolfe M
Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
[TBL] [Abstract][Full Text] [Related]
4. Natural substrates of the proteasome and their recognition by the ubiquitin system.
Ulrich HD
Curr Top Microbiol Immunol; 2002; 268():137-74. PubMed ID: 12083004
[TBL] [Abstract][Full Text] [Related]
5. Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators.
Yan F; Gao X; Lonard DM; Nawaz Z
Mol Endocrinol; 2003 Jul; 17(7):1315-31. PubMed ID: 12663742
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications.
Ciechanover A; Orian A; Schwartz AL
J Cell Biochem Suppl; 2000; 34():40-51. PubMed ID: 10762014
[TBL] [Abstract][Full Text] [Related]
7. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation.
Bays NW; Gardner RG; Seelig LP; Joazeiro CA; Hampton RY
Nat Cell Biol; 2001 Jan; 3(1):24-9. PubMed ID: 11146622
[TBL] [Abstract][Full Text] [Related]
8. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
9. Getting into position: the catalytic mechanisms of protein ubiquitylation.
Passmore LA; Barford D
Biochem J; 2004 May; 379(Pt 3):513-25. PubMed ID: 14998368
[TBL] [Abstract][Full Text] [Related]
10. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
11. Lens fibers have a fully functional ubiquitin-proteasome pathway.
Pereira P; Shang F; Hobbs M; Girão H; Taylor A
Exp Eye Res; 2003 May; 76(5):623-31. PubMed ID: 12697426
[TBL] [Abstract][Full Text] [Related]
12. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.
Van Sant C; Hagglund R; Lopez P; Roizman B
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8815-20. PubMed ID: 11447293
[TBL] [Abstract][Full Text] [Related]
13. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.
Stancovski I; Gonen H; Orian A; Schwartz AL; Ciechanover A
Mol Cell Biol; 1995 Dec; 15(12):7106-16. PubMed ID: 8524278
[TBL] [Abstract][Full Text] [Related]
14. [The ubiquitin-proteasome system: the relationship between protein degradation and human diseases].
Amir R; Ciechanover A; Cohen S
Harefuah; 2001 Dec; 140(12):1172-6, 1229. PubMed ID: 11789303
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-based anticancer therapy: carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors.
Mattern MR; Wu J; Nicholson B
Biochim Biophys Acta; 2012 Nov; 1823(11):2014-21. PubMed ID: 22610084
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin system.
Hershko A; Ciechanover A
Annu Rev Biochem; 1998; 67():425-79. PubMed ID: 9759494
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes.
Hagglund R; Van Sant C; Lopez P; Roizman B
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):631-6. PubMed ID: 11805320
[TBL] [Abstract][Full Text] [Related]
18. UbcD4, a ubiquitin-conjugating enzyme in Drosophila melanogaster expressed in pole cells.
Canning M; Kirby R; Finnegan D
Mol Genet Genomics; 2002 Feb; 266(6):907-13. PubMed ID: 11862484
[TBL] [Abstract][Full Text] [Related]
19. Feeding the machine: mechanisms of proteasome-catalyzed degradation of ubiquitinated proteins.
Crews CM
Curr Opin Chem Biol; 2003 Oct; 7(5):534-9. PubMed ID: 14580555
[TBL] [Abstract][Full Text] [Related]
20. Modes of regulation of ubiquitin-mediated protein degradation.
Kornitzer D; Ciechanover A
J Cell Physiol; 2000 Jan; 182(1):1-11. PubMed ID: 10567911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
